NCT05091723
- Conditions
- Acute Lung Injury, Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19), COVID-19, +12 more
- Locations
-
- Theravance Biopharma Investigational Site Cypress, California, United States
Clinical trial condition
Explore clinical trials studying Acute Lung Injury. Study availability and eligibility vary by location and protocol.
NCT05091723
NCT05137249
NCT05012267
NCT05089968
NCT05076240
NCT04334148
NCT04541199
NCT03905837
NCT01050699
NCT04350736